Health
FDA requires GLP-1 drugs to warn about potential vision loss risk.
NAION is an eye stroke that can cause sudden, permanent vision loss and has no proven treatment.
OriginalSourceThe IndependentUnited KingdomLeanCenter-leftCredibilityPublished20:20 UTCRatings: AllSides, MBFCSourceThe IndependentUnited KingdomLeanCenter-leftCredibilityPublished20:20 UTCRatings: AllSides, MBFC
“FDA adds rare vision-loss warning to popular GLP-1 drugs”
“The Food and Drug Administration is adding a new warning about possible rare cases of vision loss reported with popular drugs used for weight loss and diabetes, such as Ozempic”
FDA adds warning about rare vision loss for GLP-1 drugs
Key points
- FDA adds a new warning to GLP-1 weight loss and diabetes drugs.
- Eye condition non-arteritic anterior ischemic optic neuropathy can cause vision loss.
- Risk observed in about 6 of 100,000 GLP-1 users for at least one year.
- Placebo or other glucose-lowering meds show less than 4 per 100,000.
- Warnings apply to brands like Ozempic, Wegovy, Zepbound, and Mounjaro.
Other reports
- SourceSTATUnited StatesLeanCenterCredibilityRatings: AllSides, MBFCRead at STATSourceSTATUnited StatesLeanCenterCredibilityRatings: AllSides, MBFCRead at STAT
“STAT+: FDA warns GLP-1 drugs carry potential risk of rare eye condition”
- SourceMarketWatchUnited StatesOwner: Dow Jones & CompanyLeanCenterCredibilityRatings: AllSides, MBFCRead at MarketWatchSourceMarketWatchUnited StatesOwner: Dow Jones & CompanyLeanCenterCredibilityRatings: AllSides, MBFCRead at MarketWatch
“Ozempic, Zepbound and other GLP-1 drugs have a possible risk of vision loss”
- SourceQuartzUnited StatesLeanUnratedCredibilityUnratedRead at QuartzSourceQuartzUnited StatesLeanUnratedCredibilityUnratedRead at Quartz
“FDA is requiring weight loss drug makers to add a vision loss warning”
- SourceAP NewsUnited StatesLeanCenterCredibilityRatings: AllSides, MBFCRead at AP NewsSourceAP NewsUnited StatesLeanCenterCredibilityRatings: AllSides, MBFCRead at AP News
- SourceThe Washington PostUnited StatesLeanCenter-leftCredibilityRatings: AllSides, MBFCRead at The Washington PostSourceThe Washington PostUnited StatesLeanCenter-leftCredibilityRatings: AllSides, MBFCRead at The Washington Post
“FDA tells GLP-1 makers to warn of potential vision loss side effect”
- SourceNew York PostUnited StatesLeanCenter-rightCredibilityRatings: AllSides, MBFCRead at New York PostSourceNew York PostUnited StatesLeanCenter-rightCredibilityRatings: AllSides, MBFCRead at New York Post
“GLP-1 drugs must have new warning label over incurable blindness condition, says FDA”
- SourceGizmodoUnited StatesLeanUnratedCredibilityUnratedRead at GizmodoSourceGizmodoUnited StatesLeanUnratedCredibilityUnratedRead at Gizmodo
“FDA Orders New Vision Loss Warning for Ozempic and Other GLP-1s”
- SourceCBS NewsUnited StatesLeanUnratedCredibilityUnratedRead at CBS NewsSourceCBS NewsUnited StatesLeanUnratedCredibilityUnratedRead at CBS News
“FDA warns of rare vision-loss side effect from GLP-1 drugs”
How it got here
The Independent publishes the article.
concise.news reads it.
Grouped with 8 other reports as story 9.
The Brief ranks it 9th.
9 9 FDA requires GLP-1 drugs to warn about potential vision loss risk.
NAION is an eye stroke that can cause sudden, permanent vision loss and has no proven treatment.